is a boutique law firm handling complex and class action litigation, including shareholder derivative litigation, securities class actions, data breach and consumer class actions.

Current Securities Class Action Cases

Federman & Sherwood regularly posts press releases about new class action securities cases, which includes the class period and deadlines for appointment of lead plaintiffs.  Please review any of the case listings  below, and if you bought a security during the class period, we invite you to return an investor certification to our office. Our link to an investor certification for any of the cases can be found below each respective press release on that company.  Once completed, please return to our office by email to rkh@federmanlaw.com or fax to (405) 239-2112. 

Current Cases

Juno Therapeutics, Inc. [NASDAQ: JUNO]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Juno Therapeutics, Inc.

Oklahoma City, OK (July 13, 2016) – On July 12, 2016, a securities class action lawsuit was filed in the United States District Court for the Western District of Washington against Juno Therapeutics, Inc. (NASDAQ: JUNO).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is June 4, 2016 through July 7, 2016.  More specifically, this litigation was filed because the Company allegedly made misleading omissions regarding a patient death in the Phase 2 "ROCKET" trial of its lead product candidate, JCAR015. In May 2016, a patient in that trial died of a cerebral edema. Juno knew the patient death was important and consulted with the FDA about an appropriate response. Yet it failed to tell investors.  On July 7, 2016, post-market, Juno disclosed that three patients had passed away during a clinical trial.  On this news, Juno’s share declined to closed at $27.81 on July 8, 2016.

Plaintiff seeks to recover damages on behalf of all Juno Therapeutics, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above.  You may move the Court no later than Monday, September 12, 2016 to serve as a lead plaintiff for the entire Class.  However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.

To join this class action, click here to obtain an investor certification. Once complete, please email this form to rkh@federmanlaw.com, fax to us at (405) 239-2112 or send by regular mail to Federman & Sherwood, 10205 North Pennsylvania Avenue, Oklahoma City, OK 73120, ATTN:  Robin.

Copyright © 2017 Federman & Sherwood. All Rights Reserved.